Publication | Closed Access

Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women

ContraceptionHormonal ContraceptiveOral ContraceptiveMedicineGynecologyPharmacotherapyOsteoporosisHormonal Male ContraceptionYoung WomenPharmacologyOrthopaedic SurgeryWomen's Health